What does NRX Pharmaceuticals, Inc. do?

Jun 22 2025 07:11 PM IST
share
Share Via
NRX Pharmaceuticals, Inc. is a blank check company in the Pharmaceuticals & Biotechnology sector focused on business combinations. It has a market cap of $57.75 million and reported a net profit loss of $6 million as of March 2025.
Overview:
NRX Pharmaceuticals, Inc. is a blank check company in the Pharmaceuticals & Biotechnology industry, formed for the purpose of engaging in business combinations.

Financial Snapshot:
Most recent Net Profit: -6 Million (Quarterly Results - Mar 2025)
Market cap: USD 57.75 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.11
Return on Equity: 72.66%
Price to Book: -2.30

Contact Details:
Address: 2645 N Federal Hwy Ste 230, DELRAY BEACH FL: 33483-6111
Tel: 1 310 7342300
Fax: 1 302 6555049
Website: https://www.bigrockpartners.com/spac/spac_aboutus.html
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is NRX Pharmaceuticals, Inc.?
Jun 22 2025 06:22 PM IST
share
Share Via